AG-270

AG-270
Item number Size Datasheet Manual SDS Delivery time Quantity Price
TGM-T9050-1mg 1 mg

7 - 10 business days*

112.00€
TGM-T9050-5mg 5 mg

7 - 10 business days*

269.00€
TGM-T9050-10mg 10 mg

7 - 10 business days*

431.00€
TGM-T9050-25mg 25 mg

7 - 10 business days*

715.00€
TGM-T9050-50mg 50 mg

7 - 10 business days*

986.00€
TGM-T9050-100mg 100 mg

7 - 10 business days*

1,370.00€
TGM-T9050-500mg 500 mg

7 - 10 business days*

2,733.00€
 
Description: AG-270 is an allosteric and orally active inhibitor of MAT2A. Target:... more
Product information "AG-270"
Description: AG-270 is an allosteric and orally active inhibitor of MAT2A. Target: Others, Methionine Adenosyltransferase (MAT). Smiles: COc1ccc(cc1)-c1c(Nc2ccccn2)[nH]c2c(c(nn2c1=O)-c1ccccc1)C1=CCCCC1. References: Zenon Konteatis, et al. Discovery of AG-270, a First-in-Class Oral MAT2A Inhibitor for the Treatment of Tumors with Homozygous MTAP Deletion. J Med Chem. 2021 Apr 8.
Supplier: TargetMol
Supplier-Nr: T9050

Properties

Application: MAT2A (S-adenosylmethionine synthetase) inhibitor
MW: 489.57 D
Formula: C30H27N5O2

Database Information

CAS : 2201056-66-6| Matching products
KEGG ID : K00789 | Matching products

Handling & Safety

Storage: -20°C
Shipping: +4°C (International: +4°C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
Information about the product reference will follow. more
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "AG-270"
Write a review
or to review a product.
Viewed